Advances in biomarkers for optic neuritis and neuromyelitis optica spectrum disorders: a multi-omics perspective. [PDF]
Liu L, Guo K, Yang D.
europepmc +1 more source
Potential drug targets for Neuromyelitis optica spectrum disorders (NMOSD): A Mendelian randomization analysis. [PDF]
Meng H +10 more
europepmc +1 more source
Clinical and immunological differences between primary and autoimmune-associated neuromyelitis optica spectrum disorders: a retrospective study. [PDF]
Tsai HC +7 more
europepmc +1 more source
Distinct prognostic implications of blood neuronal and astroglial biomarkers in neuromyelitis optica spectrum disorders versus multiple sclerosis. [PDF]
Shin W +12 more
europepmc +1 more source
Novel Automated Chemiluminescent Immunoassay for the Detection of Autoantibodies Against Aquaporin-4 in Neuromyelitis Optica Spectrum Disorders. [PDF]
Yamazaki N +3 more
europepmc +1 more source
Clinical efficacy of efgartigimod combined with intravenous methylprednisolone in the acute phase of neuromyelitis optica spectrum disorders. [PDF]
Yang W, Chen P, Guo J, Feng H, Huang X.
europepmc +1 more source
Assessment of disability and disease burden in neuromyelitis optica spectrum disorders in the CIRCLES Cohort. [PDF]
Gholizadeh S +14 more
europepmc +1 more source
Neuromyelitis Optica Spectrum Disorders Resembling Wernicke's Encephalopathy: A Case Report and Review of Literature. [PDF]
Saito T, Nakano K, Uchiyama T.
europepmc +1 more source
Distinguishing Neuromyelitis Optica Spectrum Disorders Subtypes: A Study on AQP4 and C3d Epitope Expression in Cytokine-Primed Human Astrocytes. [PDF]
Alisch M +11 more
europepmc +1 more source

